Instructor of Medicine
Department of Medicine
Harvard Medical School
Lank Cancer for Genitourinary Oncology
Dana-Farber Cancer Institute
Senior Clinical Editor
Associate Director, Educational Strategy
Editorial Director, Hematology/Oncology
This program is intended for medical oncologists and other clinicians involved in the care of patients with advanced RCC.
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Clinical Care Options, LLC. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This program has been made available online.
Participation in this self-study activity should be completed in approximately 1.0 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from February 27, 2018, through February 26, 2019:
1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.
You must receive a test score of at least 65% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME/CE activities completed can be found on the "CME/CE Manager" page. There are no costs/fees for this activity.
In this Clinical Care Options (CCO) slideset, Dr. Elizabeth R. Plimack provides insights on managing adverse events and treatment options for advanced RCC after previous therapy
In this Clinical Care Options (CCO) slideset, Dr. Martin H. Voss provides insights on the use of first-line systemic therapy for intermediate-risk/poor-risk RCC
In this Clinical Care Options (CCO) slideset, Dr. M. Dror Michaelson provides insights on the use of first-line systemic therapy for favorable-risk RCC
Download slides from Clinical Care Options examining the optimal use of VEGFR-targeted TKIs in treating patients with solid organ tumors.
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.